The $220M cost estimate is 3.7x the affected product's trailing revenue, signaling a significant operational hit despite management's non-materiality claim. Watch for actual customer credit take-up, potential FY2027 guidance revisions, and any follow-on quality or regulatory scrutiny that could expand the scope.
Price Chart
Executive Summary
Medline initiated a voluntary field action to remove and discontinue all Medline Brand beds (homecare, bariatric, long-term care) and related accessories. Net sales of affected products were ~$60M over the trailing twelve months, and the company estimates total costs of up to $220M, to be excluded from Adjusted EBITDA and incurred in 2026-2027. Management does not expect a material impact on FY2026 financial results or prior guidance.
Key Facts
- Voluntary field action covers all Medline Brand beds, pendants, accessories, replacement parts, and bed-containing order packages.
- Affected products net sales: ~$60 million for the twelve months ended June 27, 2026.
- Estimated total costs: up to $220 million, including inventory impairment, disposal costs, and customer credits.
- Costs expected to be incurred in 2026 and 2027 and excluded from Adjusted EBITDA.
- Company does not expect a material impact on FY2026 financial results or full-year 2026 guidance (provided August 5, 2026).
Financial Impact
Up to $220 million in costs (inventory impairment, disposal, customer credits) against ~$60M in trailing revenue from affected products; costs excluded from Adjusted EBITDA.
Risk Factors
- Actual costs could exceed the $220M estimate if customer participation is higher than modeled.
- Reputational damage or regulatory follow-up could affect other Medline Brand product lines.
- Potential for further field actions or product exits if quality issues are systemic.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-117844 |
| Document: 0001104659-26-117844-index-headers.html | 0001104659-26-117844 |
| Document: 0001104659-26-117844-index.html | 0001104659-26-117844 |
| Document: 0001104659-26-117844.txt | 0001104659-26-117844 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 8-K | $34.88 | awaiting T+60 | — | $32.38 (+7.17%) |
Oct 15, 2026 12d ago | 8-K | $35.96 | awaiting T+60 | — | $32.38 (−9.96%) |
Oct 6, 2026 21d ago | Press Release | $35.55 | awaiting T+60 | — | $32.38 (−8.92%) |
Aug 5, 2026 11w ago | 8-K | $36.67 | awaiting T+60 | — | $32.38 (−11.69%) |
Aug 5, 2026 11w ago | Press Release | $36.67 | awaiting T+60 | — | $32.38 (−11.69%) |
Jul 9, 2026 15w ago | 8-K | $41.04 $35.80 | ▼ −12.77% | ▼ −15.40% | $32.38 (−21.10%) |
Jun 11, 2026 19w ago | Institutional Cluster | $37.13 $36.59 | ▼ −1.45% | ▼ −5.85% | $32.38 (−12.79%) |
Jun 2, 2026 21w ago | 8-K | $33.19 $34.58 | ▲ +4.19% | ▲ +3.07% | $32.38 (−2.44%) |
Jun 1, 2026 21w ago | Insider Cluster | $33.19 $34.58 | ▼ −4.19% | ▼ −3.07% | $32.38 (+2.44%) |
Jun 1, 2026 21w ago | Insider Cluster | $33.19 $34.58 | ▼ −4.19% | ▼ −3.07% | $32.38 (+2.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers